📅 PUBMED DAILY TRIAGE — 2026-11-12 Window: 2026-11-11T10:19:56Z → 2026-11-12T10:19:56Z (CRDT) Topics scanned: 10 | Articles reviewed: 124 | Candidates evaluated: 130 High priority: 7 | Standard: 38 | Low/archive: 0 | Unsolicited finds: 3 Run status: SUCCESS
🔴🟠 HIGH PRIORITY (8+) — Best Finds by Topic
- Hematologic malignancies: No high-priority finds today (best candidate scored 7/10)
- CBC-based diagnostics and machine learning in hematology: No high-priority finds today (best candidate scored 0/10)
Early cancer detection
PMID-43013192 · Postoperative Tumor-Informed Circulating Tumor DNA Status for Molecular Residual Disease Detection After Curative-Intent Resection of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis. · 8/10 · Postoperative tumor-informed ctDNA positivity was associated with an increased recurrence risk and inferior survival after curative-intent PDAC treatment, although a negative result did not reliably exclude residual disease.
- AI/ML in clinical diagnostics and imaging: No high-priority finds today (best candidate scored 7/10)
Precision oncology and genomic medicine
PMID-43013345 · SPROUT Guidelines for Molecular Profiling for Children with Solid Tumors: A Consensus Recommendation from the American Association for Cancer Research. · 8/10 · The SPROUT Molecular Guidelines provide a framework for standardized implementation of molecular diagnostics in pediatric solid tumors.
- Novel therapeutics: No high-priority finds today (best candidate scored 7/10)
Cardiovascular-metabolic
PMID-43014327 · Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 48-week results from a multicentre, randomised, double-blind, phase 2b study. · 9/10 · In patients with MASH, 48 weeks of pemvidutide treatment led to significant reductions in non-invasive tests of MASH inflammation and fibrosis, suggesting continued improvement in liver health. PMID-43014326 · Trevogrumab (anti-GDF8) with or without garetosmab (anti-activin A) for prevention of muscle loss during semaglutide-induced weight reduction in people with obesity (COURAGE): a two-part, phase 2, double-blind, placebo-controlled, randomised trial. · 9/10 · This study establishes proof of concept for GDF8 inhibition by trevogrumab alone as a generally well tolerated strategy to preserve lean mass during GLP-1 receptor agonist-induced weight loss. PMID-43013292 · First and Subsequent Major Cardiovascular Events With Oral Semaglutide in High-Risk Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial. · 8/10 · Oral semaglutide reduced the risk of first plus subsequent 3-P MACE vs placebo, highlighting the benefit of oral semaglutide in reducing the total burden of clinical morbidity and mortality in this high-risk population.
- Aging, longevity, and population health: No high-priority finds today (best candidate scored 7/10)
Rare diseases with high unmet need
PMID-43014040 · Regional newborn screening for Gaucher disease in Kumamoto and Fukuoka Prefectures, Japan: an updated report and long-term outcomes of screen-identified patients. · 8/10 · Regional newborn screening identified Gaucher disease across a broad and evolving phenotype spectrum and enabled longitudinal follow-up of screen-detected children.
Sentinel scan
PMID-43014336 · Interventions to reduce paediatric cancer treatment abandonment in low-income and middle-income countries: a systematic review and meta-analysis. · 8/10 · Across 24 studies, interventions were associated with a pooled 67% reduction in paediatric cancer treatment abandonment, although heterogeneity and methodological limitations reduced certainty.
🟢⚪ STANDARD (5-7) — Top by Topic
Hematologic malignancies
PMID-43014544 · Thiotepa/Busulfan/Cyclophosphamide versus Busulfan/Thiotepa Conditioning For Autologous Stem Cell Transplantation in CNS Lymphoma: A Single-Center Comparative and Descriptive Experience. · 7/10 · Treatment Innovation PMID-43013361 · Social vulnerability index associates with chronic lymphocytic leukemia survival rates in the Detroit tri-county area. · 7/10 · Public Health PMID-43013347 · Primary mediastinal large B-cell lymphoma genomic profiling demonstrates thymic B-cell identity and frequent aberrant somatic hypermutation. · 7/10 · Genomics/Precision Medicine PMID-43010748 · [Mitoxantrone hydrochloride liposomes combined with R-GDP regimen in the treatment of relapsed/refractory diffuse large B-cell lymphoma: a single-arm, multicenter, exploratory clinical study]. · 7/10 · Treatment Innovation PMID-43013712 · Elevated UHRF1 predicts unfavorable clinical outcomes in adult T-cell leukemia/lymphoma: Clinicopathological analysis and preliminary in vitro observations. · 6/10 · Genomics/Precision Medicine
CBC-based diagnostics and machine learning in hematology
No retained standard-priority articles.
Early cancer detection
PMID-43012102 · Long-term economic benefits of early cancer detection through enhanced multimodal screening: a modeling study of whole-body MRI and liquid biopsy. · 7/10 · Early Detection PMID-43015135 · Biomarker-led advances in renal cell carcinoma diagnosis, progression monitoring and therapeutic decision-making. · 6/10 · Early Detection PMID-43013996 · Targeted liquid biopsy using CEUS to facilitate the release of ctDNA in colorectal liver metastasis. · 6/10 · Early Detection PMID-43010450 · High-Purity Magnetic Fluidic Isolation of Viable Circulating Tumor Cells Enables Single-Cell Multi-Omics Profiling. · 5/10 · Early Detection PMID-43010441 · Simple and Isolation-Free Analysis of Tumor-Derived Extracellular Vesicles by Aggregation-Modulated Deterministic Lateral Displacement for Breast Cancer Classification. · 5/10 · Early Detection
AI/ML in clinical diagnostics and imaging
PMID-43014489 · Deep learning-based estimation of multi-tracer PET phenotypes from structural MRI for A/T/N-related analysis and progression prediction in Alzheimer's disease. · 7/10 · Diagnostics PMID-43013774 · Imaging-Based AI for Predicting Pathological Complete Response in Esophageal Cancer After Neoadjuvant Therapy: Systematic Review and Meta-Analysis. · 7/10 · Diagnostics PMID-43015201 · Video-based Deep Learning for Pulmonary Embolism Classification on Paired Contrast-enhanced and Noncontrast Chest CT: A Single-center Retrospective Feasibility Study. · 6/10 · Diagnostics PMID-43014415 · Evaluating Multimodal Vision Frontier Models for Grading Neuroforaminal Stenosis on Lumbar Spine MRIs. · 6/10 · Diagnostics PMID-43014110 · Automated cephalometric landmark detection with a dual-encoder regression network in adolescent and adult cephalograms: A retrospective diagnostic accuracy study on three public datasets. · 6/10 · Diagnostics
Precision oncology and genomic medicine
PMID-43013680 · Frequency of pharmacogenomic variation and medication exposures among participants in the All of Us Research Program. · 7/10 · Genomics/Precision Medicine PMID-43013347 · Primary mediastinal large B-cell lymphoma genomic profiling demonstrates thymic B-cell identity and frequent aberrant somatic hypermutation. · 7/10 · Genomics/Precision Medicine PMID-43015004 · A machine learning-based predictive tool for complete renal response in lupus nephritis leverages the 3-month treatment milestone. · 6/10 · Genomics/Precision Medicine PMID-43013458 · Genetic determinants of direct oral anticoagulant (DOAC) response: evidence, limitations and barriers to clinical implementation. · 6/10 · Genomics/Precision Medicine PMID-43013436 · Structure-Aware Dual-Teacher Distillation Enables Robust Multitask Drug Discovery in Data-Scarce Regimes. · 5/10 · Drug Development
Novel therapeutics
PMID-43014598 · HSA-coated intrinsically radiolabeled [(177)Lu]Lu₂O₃ nanoparticles for injectable nanoscale brachytherapy: Preclinical validation and first-in-human imaging. · 7/10 · Drug Development PMID-43014538 · Comprehensive Immunoprofiling and Multi-Omics Modeling Reveal Key Immune Features Associated with Disease Progression and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma. · 6/10 · Treatment Innovation PMID-43014547 · Traversing the Last Mile: Bringing Chimeric Antigen Receptor T-Cell Therapy to the Community Setting. · 5/10 · Treatment Innovation PMID-43013848 · Berberine/Verteporfin Nanomicelles Enable O2-Economized Photodynamic Immunotherapy in Esophageal Cancer Via Tumor Metabolic Remodeling. · 5/10 · Drug Development PMID-43013741 · Bacteroidetes promote hepatocellular carcinoma progression and resistance to immunotherapy. · 5/10 · Treatment Innovation
Cardiovascular-metabolic
PMID-43014742 · GLP-1-based Therapies in MASH: From Metabolic Benefits to an Improvement in Liver Fibrosis. · 6/10 · Treatment Innovation PMID-43012895 · Association of metabolic insulin resistance with white matter hyperintensity burden and plasma proteomic signatures in the UK Biobank. · 6/10 · Prevention PMID-43011228 · GLP-1 based therapy of obesity and type 2 diabetes. · 6/10 · Treatment Innovation PMID-43014519 · Cross-sectional Associations of Ultra-processed Food Intake with Cardiometabolic Risk Differ by Nutritional Quality. · 5/10 · Prevention
Aging, longevity, and population health
PMID-43013474 · Potentially modifiable mediators of the association between child abuse and dementia. · 7/10 · Public Health PMID-43010179 · Human cognitive performance-associated gut microbiota influences learning and memory in mice through arginine and pterin metabolism. · 7/10 · Public Health PMID-43012776 · A scoping review of the application of intelligent technology in medication adherence among older adults with chronic diseases. · 6/10 · Public Health PMID-43010539 · Immunophenotypic Profiles of General Chinese Population during Natural Aging. · 6/10 · Public Health PMID-43014987 · Dementia and Neurodegenerative Disease: Emerging Neurodegenerative Diseases-Limbic-predominant age-related TDP-43 encephalopathy/Hippocampal Sclerosis, Argyrophilic Grain Disease, Primary Age-Related Tauopathy, and Frontotemporal Dementia Fused in Sarcoma. · 5/10 · Diagnostics
Rare diseases with high unmet need
PMID-43013562 · Structural distance to the tRNA-synthetase binding interface predicts pathogenicity but is captured by AlphaMissense and EVE. · 6/10 · Genomics/Precision Medicine PMID-43011792 · Awareness and Acceptance of Gene Therapy for Sickle Cell Disease Among Individuals From the Eastern Province of Saudi Arabia: A Cross-Sectional Study. · 5/10 · Public Health PMID-43011156 · Medical practitioners' perceptions of adverse event reporting for rare diseases in South Africa. · 5/10 · Public Health
Sentinel scan
PMID-43011506 · Prospective Multicenter Evaluation of a Novel Low-Axial-Force Colonic Stent for Malignant Colorectal Obstruction. · 7/10 · Treatment Innovation PMID-43014985 · Molecular Neuroimaging in Alzheimer's Disease. · 6/10 · Diagnostics
💡 UNSOLICITED FINDS
PMID-43014336 · Interventions to reduce paediatric cancer treatment abandonment in low-income and middle-income countries: a systematic review and meta-analysis. · 8/10 · Across 24 studies, interventions were associated with a pooled 67% reduction in paediatric cancer treatment abandonment, although heterogeneity and methodological limitations reduced certainty.
📊 TODAY'S BREAKDOWN
- By research category: Treatment Innovation 10 | Public Health 8 | Diagnostics 7 | Early Detection 7 | Genomics/Precision Medicine 7 | Drug Development 3 | Prevention 3
- By evidence maturity: Exploratory 35 | Validated 10
- By watchlist topic:
- Hematologic malignancies: 15 reviewed / 5 kept / highest 7
- CBC-based diagnostics and machine learning in hematology: 1 reviewed / 0 kept / highest 0
- Early cancer detection: 15 reviewed / 6 kept / highest 8
- AI/ML in clinical diagnostics and imaging: 15 reviewed / 5 kept / highest 7
- Precision oncology and genomic medicine: 15 reviewed / 6 kept / highest 8
- Novel therapeutics: 15 reviewed / 5 kept / highest 7
- Cardiovascular-metabolic: 15 reviewed / 7 kept / highest 9
- Aging, longevity, and population health: 15 reviewed / 5 kept / highest 7
- Rare diseases with high unmet need: 14 reviewed / 4 kept / highest 8
- Sentinel scan: 10 reviewed / 3 kept / highest 8
- By source type: peer_reviewed 45 | preprint 0
- Topics with zero 8+ articles this run: Hematologic malignancies; CBC-based diagnostics and machine learning in hematology; AI/ML in clinical diagnostics and imaging; Novel therapeutics; Aging, longevity, and population health
🔧 RUN NOTES
- Complete same-date rerun: prior article emissions were not used to suppress daily JSON records.
- All 124 unique candidate PMIDs were confirmed by ESummary and EFetch; no endpoint PMIDs were missing.
- Per-topic caps were 15 for watchlist searches and 10 for the sentinel scan; capped searches record truncation explicitly.
- The sole CBC/ML candidate was reviewed but excluded as off-topic, leaving complete coverage with zero genuine retained articles.
- Publication-type Letters, Comments, Interviews, and Published Errata were removed before scoring.
- No 48-hour expansion was needed because the retained corpus exceeded the minimum relevance threshold.